Search

Your search keyword '"Sattler, Martin"' showing total 749 results

Search Constraints

Start Over You searched for: Author "Sattler, Martin" Remove constraint Author: "Sattler, Martin" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
749 results on '"Sattler, Martin"'

Search Results

3. Exploring the accessibility of primary health care data in Europe's COVID-19 response: developing key indicators for managing future pandemics (Eurodata study)

4. Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome

6. Formação (Bildung): entre o sagrado e o profano = Education (Bildung): between the sacred and the profane

8. Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.

9. EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.

12. JunB is a key regulator of multiple myeloma bone marrow angiogenesis

13. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma

14. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)

16. Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study

17. Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma

18. Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study

19. Current therapies under investigation for COVID-19: potential COVID-19 treatments

22. General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries

24. Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

25. Patient Characteristics and General Practitioners’ Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries

28. Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis

29. Critical role for Gab2 in transformation by BCR/ABL.

30. Abstract 6248: Inhibiting β-catenin in AML by targeting DDX5

31. Supplementary Table I from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

32. Supplementary Figures 1-7 from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

33. Data from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

34. Supplementary Figure Legends from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

35. Supplementary Figures from Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R

36. Supplementary Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

37. Supplementary Figure Legends from Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R

38. Data from Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R

39. Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

40. Supplementary Table 2 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

41. Supplementary Figure 2 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

42. Supplementary Figure 3 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

43. Supplementary Figure 4 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

44. Data from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

45. Supplementary Table 1 from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma

46. Supplementary Figure 1 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

47. Supplementary Table 4 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

48. Supplementary Figure 5 from Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

49. Supplementary Data 1-4, Table from Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1α–Dependent Pathway in Multiple Myeloma

50. Supplementary Legends and Figures 1-2 from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma

Catalog

Books, media, physical & digital resources